FBXW7 and metabolic dysfunction-associated steatohepatitis: We also uncover ERRα as a transcriptional regulator of Fbxw7 expression thus establishing a regulatory feedback loop, and further demonstrate the potential for pharmacological inhibition of uncontrolled ERRα activity to manage NASH.